| 臺大學術典藏 |
2021-06-25T08:10:15Z |
Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan
|
Liu C.-H.; Liu C.-J.; Su T.-H.; Yang H.-C.; CHUN-MING HONG; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-09-04T05:17:09Z |
Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan
|
Liu C.-H.; Liu C.-J.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-02-27T06:48:01Z |
Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan
|
Tseng, Tai-Chung;JIA-HORNG KAO;DING-SHINN CHEN;PEI-JER CHEN;CHUN-MING HONG;HUNG-CHIH YANG;TUNG-HUNG SU;CHUN-JEN LIU;CHEN-HUA LIU; CHEN-HUA LIU; CHUN-JEN LIU; TUNG-HUNG SU; HUNG-CHIH YANG; CHUN-MING HONG; Tseng, Tai-Chung; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-03-09T01:43:20Z |
Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan
|
Liu C.-H.; Liu C.-J.; TUNG-HUNG SU; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:25Z |
Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan
|
CHEN-HUA LIU; Liu C.-J.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-06-25T08:10:13Z |
Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan
|
Liu C.-H.; Liu C.-J.; Su T.-H.; Yang H.-C.; CHUN-MING HONG; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:29Z |
Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan
|
Liu C.-H; | Liu C.-J; | Su T.-H; | HUNG-CHIH YANG; | Hong C.-M; | Tseng T.-C; | Chen P.-J; | Chen D.-S; | Kao J.-H. |
| 臺大學術典藏 |
2021-09-04T05:16:58Z |
Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan
|
Liu C.-H.; Liu C.-J.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-01-24T09:31:17Z |
Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan
|
Liu C.-H.; CHUN-JEN LIU; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:33:35Z |
Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan
|
Liu C.-H.; Liu C.-J.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 國立成功大學 |
2019-05 |
Real-world effectiveness and safety of sofosbuvir plus daclatasvir with or without ribavirin for genotype 2 chronic hepatitis C in Taiwan
|
Cheng;Pin-Nan;Chiu;Yen-Cheng;Chien;Shih-Chieh;Chiu;Hung-Chih |
| 國立成功大學 |
2022-11 |
Real-world effectiveness and safety of sofosbuvir/velpatasvir and glecaprevir/ pibrentasvir for genotype 6 chronic hepatitis C
|
Chen;Jyh-Jou;Chiu;Yen-Cheng;Lee;Pei-Lun;Tung;Hung-Da;Chiu;Hung-Chih;Chien;Shih-Chieh;Cheng;Pin-Nan |
| 國立成功大學 |
2022 |
Real-world effectiveness and safety of sofosbuvir/velpatasvir and glecaprevir/pibrentasvir for genotype 6 chronic hepatitis C
|
Chen, J.-J.;Chiu, Y.-C.;Lee, P.-L.;Tung, H.-D.;Chiu, H.-C.;Chien, S.-C.;Cheng, P.-N. |
| 臺大學術典藏 |
2021-03-09T01:43:14Z |
Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral Therapy
|
Yang H.-I.; Yeh M.-L.; Wong G.L.; Peng C.-Y.; Chen C.-H.; Trinh H.N.; Cheung K.-S.; Xie Q.; TUNG-HUNG SU; Kozuka R.; Lee D.-H.; Ogawa E.; Zhao C.; Ning H.-B.; Huang R.; Li J.; Zhang J.Q.; Ide T.; Xing H.; Iwane S.; Takahashi H.; Wong C.; Wong C.; Lin C.-H.; Hoang J.; Le A.; Henry L.; Toyoda H.; Ueno Y.; Gane E.J.; Eguchi Y.; Kurosaki M.; Wu C.; Liu C.; Shang J.; Furusyo N.; Enomoto M.; Kao J.-H.; Yuen M.-F.; Yu M.-L.; Nguyen M.H. |
| 臺大學術典藏 |
2021-09-04T05:16:43Z |
Real-world effectiveness from the asia pacific rim liver consortium for hbv risk score for the prediction of hepatocellular carcinoma in chronic hepatitis b patients treated with oral antiviral therapy
|
Yang H.-I.; Yeh M.-L.; Wong G.L.; Peng C.-Y.; Chen C.-H.; Trinh H.N.; Cheung K.-S.; Xie Q.; Su T.-H.; Kozuka R.; Lee D.-H.; Ogawa E.; Zhao C.; Ning H.-B.; Huang R.; Li J.; Zhang J.Q.; Ide T.; Xing H.; Iwane S.; Takahashi H.; Wong C.; Wong C.; Lin C.-H.; Hoang J.; Le A.; Henry L.; Toyoda H.; Ueno Y.; Gane E.J.; Eguchi Y.; Kurosaki M.; Wu C.; Liu C.; Shang J.; Furusyo N.; Enomoto M.; JIA-HORNG KAO; Yuen M.-F.; Yu M.-L.; Nguyen M.H. |
| 臺大學術典藏 |
2021-06-25T08:10:12Z |
Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data
|
CHUN-MING HONG; Liu C.-H.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen Y.-W.; Kao J.-H.; Liu C.-J. |
| 臺大學術典藏 |
2021-07-03T03:33:23Z |
Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data
|
Hong C.-M.; Liu C.-H.; Su T.-H.; Yang H.-C.; PEI-JER CHEN; Chen Y.-W.; Kao J.-H.; Liu C.-J. |
| 臺大學術典藏 |
2021-03-09T01:43:11Z |
Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data
|
Hong C.-M.; Liu C.-H.; TUNG-HUNG SU; Yang H.-C.; Chen P.-J.; Chen Y.-W.; Kao J.-H.; Liu C.-J. |
| 臺大學術典藏 |
2021-05-24T07:20:16Z |
Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data
|
Hong C.-M.; CHEN-HUA LIU; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen Y.-W.; Kao J.-H.; Liu C.-J. |
| 臺大學術典藏 |
2021-07-12T02:44:23Z |
Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data
|
Hong C.-M; | Liu C.-H; | Su T.-H; | HUNG-CHIH YANG; | Chen P.-J; | Chen Y.-W; | Kao J.-H; | Liu C.-J. |
| 臺大學術典藏 |
2022-01-24T09:31:06Z |
Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data
|
Hong C.-M.; Liu C.-H.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen Y.-W.; Kao J.-H.; CHUN-JEN LIU |
| 臺大學術典藏 |
2020 |
Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data
|
Liu C.-J.; Kao J.-H.; Chen Y.-W.; Chen P.-J.; Yang H.-C.; Su T.-H.; CHEN-HUA LIU; Hong C.-M. |
| 臺大學術典藏 |
2021-09-04T05:16:33Z |
Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data
|
Hong C.-M.; Liu C.-H.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen Y.-W.; JIA-HORNG KAO; Liu C.-J. |
| 嘉南藥理大學 |
2022 |
Real-world effectiveness of direct-acting antivirals in people living with human immunodeficiency virus and hepatitis C virus genotype 6 infections
|
Sun, Hsin-Yun; Cheng, Chien-Yu; Lin, Chi-Ying; Yang, Chia-Jui; Lee, Nan-Yao; Liou, Bo-Huang; Tang, Hung-Jen; Liu, Yuang-Meng; Lee, Chun-Yuan; Chen, Tun-Chieh; Huang, Yi-Chia; Lee, Yuan-Ti; Tsai, Ming-Jui; Lu, Po-Liang; Tsai, Hung-Chin; Wang, Ning-Chi; Hung, Tung-Che; Cheng, Shu-Hsing; Hung, Chien-Ching |
| 臺大學術典藏 |
2022-04-14T23:27:16Z |
Real-world effectiveness of direct-acting antivirals in people living with human immunodeficiency virus and hepatitis C virus genotype 6 infections
|
HSIN-YUN SUN; Cheng, Chien Yu; Lin, Chi Ying; Yang, Chia Jui; Lee, Nan Yao; Liou, Bo Huang; Tang, Hung Jen; Liu, Yuang Meng; Lee, Chun Yuan; Chen, Tun Chieh; Huang, Yi Chia; Lee, Yuan Ti; Tsai, Ming Jui; Lu, Po Liang; Tsai, Hung Chin; Wang, Ning Chi; Hung, Tung Che; Cheng, Shu Hsing; CHIEN-CHING HUNG |
| 臺大學術典藏 |
2022-05-25T05:47:44Z |
Real-world effectiveness of direct-acting antivirals in people living with human immunodeficiency virus and hepatitis C virus genotype 6 infections
|
HSIN-YUN SUN; Cheng, Chien-Yu; Lin, Chi-Ying; Yang, Chia-Jui; Lee, Nan-Yao; Liou, Bo-Huang; Tang, Hung-Jen; Liu, Yuang-Meng; Lee, Chun-Yuan; Chen, Tun-Chieh; Huang, Yi-Chia; Lee, Yuan-Ti; Tsai, Ming-Jui; Lu, Po-Liang; Tsai, Hung-Chin; Wang, Ning-Chi; Hung, Tung-Che; Cheng, Shu-Hsing; Hung, Chien-Ching |
| 臺大學術典藏 |
2022-09-15T05:42:28Z |
Real-world effectiveness of direct-acting antivirals in people living with human immunodeficiency virus and hepatitis C virus genotype 6 infections
|
Sun H.-Y.; Cheng C.-Y.; Lin C.-Y.; Yang C.-J.; Lee N.-Y.; Liou B.-H.; Tang H.-J.; Liu Y.-M.; Lee C.-Y.; Chen T.-C.; Huang Y.-C.; Lee Y.-T.; Tsai M.-J.; Lu P.-L.; Tsai H.-C.; Wang N.-C.; Hung T.-C.; Cheng S.-H.; CHIEN-CHING HUNG |
| 國立成功大學 |
2022 |
Real-world effectiveness of direct-acting antivirals in people living with human immunodeficiency virus and hepatitis C virus genotype 6 infections
|
Sun, H.-Y.;Cheng, Cheng C.-Y.;Lin, C.-Y.;Yang, C.-J.;Lee, N.-Y.;Liou, B.-H.;Tang, H.-J.;Liu, Y.-M.;Lee, C.-Y.;Chen, T.-C.;Huang, Y.-C.;Lee, Y.-T.;Tsai, M.-J.;Lu, P.-L.;Tsai, H.-C.;Wang, N.-C.;Hung, T.-C.;Cheng, S.-H.;Hung, C.-C. |
| 臺大學術典藏 |
2022-02-22T05:34:11Z |
Real-world effectiveness of glecaprevir/pibrentasvir and ledipasvir/sofosbuvir for mixed genotype hepatitis C infection: A multicenter pooled analysis in Taiwan
|
Chiu W.-N.; Hung C.-H.; Lu S.-N.; Chen M.-Y.; Tung S.-Y.; Wei K.-L.; Lu C.-K.; CHIEN-HUNG CHEN; Hu T.-H.; Hu J.-H.; Chen W.-M.; Chang T.-S. |
| 臺大學術典藏 |
2022-02-23T02:12:22Z |
Real-world effectiveness of glecaprevir/pibrentasvir and ledipasvir/sofosbuvir for mixed genotype hepatitis C infection: A multicenter pooled analysis in Taiwan
|
Chiu W.-N.; Hung C.-H.; Lu S.-N.; Chen M.-Y.; Tung S.-Y.; Wei K.-L.; Lu C.-K.; CHIEN-HUNG CHEN; Hu T.-H.; Hu J.-H.; Chen W.-M.; Chang T.-S. |
| 國立成功大學 |
2021 |
Real-world effectiveness of hyperbaric oxygen therapy for delayed neuropsychiatric sequelae after carbon monoxide poisoning
|
Liao, S.-C.;Shao, Shao S.-C.;Yang, K.-J.;Yang, C.-C. |
| 臺大學術典藏 |
2019-07-26T06:32:02Z |
Real-world effectiveness of medications on survival in patients with COPD-heart failure overlap
|
Yang K.-Y.;Pau-Chung Chen;Su W.-J.;Su K.-C.;Chou K.-T.;Tsai Y.-H.;Perng D.-W.;Yang Y.-H.;Su V.Y.-F.; Su V.Y.-F.; Yang Y.-H.; Perng D.-W.; Tsai Y.-H.; Chou K.-T.; Su K.-C.; Su W.-J.; PAU-CHUNG CHEN; Yang K.-Y. |
| 臺大學術典藏 |
2022-03-31T02:38:31Z |
Real-world effectiveness of medications on survival in patients with COPD-heart failure overlap
|
Su V.Y.-F.; Yang Y.-H.; Perng D.-W.; Tsai Y.-H.; Chou K.-T.; Su K.-C.; Su W.-J.; PAU-CHUNG CHEN; Yang K.-Y. |
| 臺大學術典藏 |
2022-05-03T03:02:17Z |
Real-world effectiveness of second-line Afatinib versus chemotherapy for the treatment of advanced lung squamous cell carcinoma in immunotherapy-na?ve patients
|
Chen Y.-Y.; Chang S.-C.; Chang C.-Y.; Chang C.-F.; Lai Y.-C.; Wei Y.-F.; CHUNG-YU CHEN |
| 國家衛生研究院 |
2023-01-30 |
Real-world effectiveness of sorafenib versus lenvatinib combined with PD-1 inhibitors in unresectable hepatocellular carcinoma
|
Chiang, HC;Lee, YC;Chang, TT;Lin, YJ;Wu, HT;Wang, CT;Chen, CY;Chen, PJ;Hsieh, MT;Lin, SH;Chen, SH;Chuang, CH;Wu, IC;Hong, TC;Wu, JS;Han, MZ;Chen, WT;Chiang, CM;Hung, KK;Kuo, HY |
| 國立成功大學 |
2023-02 |
Real-World Effectiveness of Sorafenib versus Lenvatinib Combined with PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma
|
Chiang;Hsueh-Chien;Lee;Yang-Cheng;Chang;Ting-Tsung;Lin;Yih-Jyh;Wu;Hung-Tsung;Wang;Chung-Teng;Chen;Chiung-Yu;Chen;Po-Jun;Hsieh;Ming-Tsung;Lin;Sheng-Hsiang;Chen;Shang-Hung;Chuang;Chiao-Hsiung;Wu;I-Chin;Hong;Tzu-Chun;Wu;Juei-Seng;Han;Meng-Zhi;Chen;Wei-Ting;Chiang;Chien-Ming;Hung;Kuan-Kai;Kuo;Hsin-Yu |
| 中山醫學大學 |
2021 |
Real-world efficacy and safety of lorlatinib in treating advanced ALK-positive non-small cell lung cancer patients
|
Lee, PH; Chen, KC; Hsu, KH; Huang, YH; Tseng, JS; Yang, TY; Chang, GC |
| 國立成功大學 |
2020-12-29 |
Real-world efficacy of biological agents in moderate-to-severe plaque psoriasis: An analysis of 75 patients in Taiwan
|
Chen;Yu-Chen;Huang;Yi-Ting;Yang;Chao-Chun;Lai;Edward, Chia-Cheng;Liu;Cheng-Han;Hsu;Chao-Kai;Wong;Tak-Wah;Chao;Sheau-Chiou;Sheu;Hamm-Ming;Lee;Chaw-Ning |
| 國立成功大學 |
2015 |
Real-world evaluation of compliance and preference in Alzheimer's disease treatment
|
Pai, Ming-Chyi; Aref, Hany; Bassil, Nazem; Kandiah, Nagaendran; Lee, Jae-Hong; Srinivasan, A. V.; diTommaso, Shelley; Yuksel, Ozgur |
| 國立成功大學 |
2016 |
Real-world evaluation of compliance and preference in Alzheimer's disease treatment: an observational study in Taiwan
|
Lai, Tzu-Hsien; Wang, Wen-Fu; Yip, Bak-Sau; Yang, Yu-Wan; Peng, Giia-Sheun; Tsai, Shih-Jei; Liao, Yi-Chu; Pai, Ming-Chyi |
| 臺大學術典藏 |
2021-09-17T06:19:48Z |
Real-World Evaluation of Modern Adjuvant Radiotherapy in Women with Stage IB Endometrial Cancer
|
Chen, Jenny Ling-Yu; Huang, Chao-Yuan; YU-SEN HUANG; Hsu, Che-Yu; Lan, Keng-Hsueh; Shih, I-Lun; Cheng, Wen-Fang; Chen, Chi-An; BOR-CHING SHEU; Kuo, Sung-Hsin |
| 臺大學術典藏 |
2021-10-04T06:16:56Z |
Real-World Evaluation of Modern Adjuvant Radiotherapy in Women with Stage IB Endometrial Cancer
|
Chen, Jenny Ling-Yu; Huang, Chao-Yuan; YU-SEN HUANG; Hsu, Che-Yu; Lan, Keng-Hsueh; Shih, I-Lun; Cheng, Wen-Fang; CHI-AN CHEN; Sheu, Bor-Ching; Kuo, Sung-Hsin |
| 臺大學術典藏 |
2021-12-16T05:29:51Z |
Real-World Evaluation of Modern Adjuvant Radiotherapy in Women with Stage IB Endometrial Cancer
|
Chen, Jenny Ling-Yu; Huang, Chao-Yuan; YU-SEN HUANG; Hsu, Che-Yu; Lan, Keng-Hsueh; I-LUN SHIH; Cheng, Wen-Fang; Chen, Chi-An; Sheu, Bor-Ching; Kuo, Sung-Hsin |
| 臺大學術典藏 |
2021-09-17T06:58:51Z |
Real-World Evaluation of Modern Adjuvant Radiotherapy in Women with Stage IB Endometrial Cancer
|
Chen, Jenny Ling-Yu; Huang, Chao-Yuan; YU-SEN HUANG; Hsu, Che-Yu; Lan, Keng-Hsueh; Shih, I-Lun; WEN-FANG CHENG; Chen, Chi-An; Sheu, Bor-Ching; Kuo, Sung-Hsin |
| 國立成功大學 |
2021-01-12 |
Real-world evidence and optimization of vocal dysfunction in end-stage renal disease patients with secondary hyperparathyroidism
|
Chang;Geng-He;Chou;Fong-Fu;Tsai;Ming-Shao;Tsai;Yao-Te;Yang;Ming-Yu;Huang;Ethan;I;Su;Hui-Chen;Hsu;Cheng-Ming |
| 國立成功大學 |
2023 |
Real-World Evidence of Effectiveness and Safety of Vedolizumab for Inflammatory Bowel Disease inTaiwan: A Prospective Nationwide Registry (VIOLET) Study
|
Lin, W.-C.;Tai, W.-C.;Chang, Chang C.-H.;Tu, C.-H.;Feng, I.-C.;Shieh, M.-J.;Chung, Chung C.-S.;Yen, H.-H.;Chou, J.-W.;Wong, J.-M.;Liu, Y.-H.;Huang, T.-Y.;Chuang, Chuang C.-H.;Tsai, Tsai T.-J.;Chiang, F.-F.;Lu, C.-Y.;Hsu, W.-H.;Yu, F.-J.;Chao, T.-H.;Wu, D.-C.;Ho, A.-S.;Lin, H.-H.;Feng, C.-L.;Wu, K.-L.;Wong, M.-W.;Tung, C.-C.;Lin, C.-C.;Chen, Chen C.-C.;Hu, Hu H.-M.;Lu, Lu L.-S.;Wang, H.-S.;Wu, I.-C.;Kuo, H.-Y.;Wu, J.-F.;Shih, H.Y.;Ni, Y.-H.;Tang, S.-L.;Chen, P.-H.;Wei, S.-C. |
| 國家衛生研究院 |
2023-05 |
Real-world evidence of hyperbaric oxygen therapy on cardiovascular outcomes in patients with chronic osteomyelitis
|
Tai, CJ;Lu, CK;Lee, CY;Lee, SS;Yang, YH |
| 國立成功大學 |
2021 |
Real-world evidence of population differences in allopurinol-related severe cutaneous adverse reactions in East Asians: A population-based cohort study
|
Sato, T.;Cheng, Cheng C.-L.;Park, H.-W.;Kao, Yang Y.-H.;Yang, M.-S.;Fujita, M.;Kumagai, Y.;Tohkin, M.;Saito, Y.;Sai, K. |
| 臺大學術典藏 |
2021-01-28T01:06:14Z |
Real-world evidence of the safety and effectiveness of regorafenib in Taiwanese patients with metastatic colorectal cancer: CORRELATE Taiwan
|
Kun-Huei Yeh;Yang T.-S.;Hsu T.-C.;Tzu-Liang Chen W.;Chen H.-H.;Teng H.-W.;Lin B.-W.;Kuan F.-C.;Chiang F.-F.;Duann C.-W.;Li Y.-S.;Lin M.-T.;Fiala-Buskies S.;Ducreux M.;Wang J.-Y.; KUN-HUEI YEH; Yang T.-S.; Hsu T.-C.; Tzu-Liang Chen W.; Chen H.-H.; Teng H.-W.; Lin B.-W.; Kuan F.-C.; Chiang F.-F.; Duann C.-W.; Li Y.-S.; Lin M.-T.; Fiala-Buskies S.; Ducreux M.; Wang J.-Y. |
| 國立成功大學 |
2021 |
Real-world evidence of the safety and effectiveness of regorafenib in Taiwanese patients with metastatic colorectal cancer: CORRELATE Taiwan
|
Yeh, K.-H.;Yang, T.-S.;Hsu, T.-C.;Tzu-Liang, Chen W.;Chen, H.-H.;Teng, H.-W.;Lin, B.-W.;Kuan, F.-C.;Chiang, F.-F.;Duann, C.-W.;Li, Y.-S.;Lin, M.-T.;Fiala-Buskies, S.;Ducreux, M.;Wang, J.-Y. |
